Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Novel technologies for virtual screening.

Thomas Lengauer1, Christian Lemmen, Matthias Rarey

  • 1Max-Planck Institute for Informatics, Stuhlsatzenhausweg 85, 66123 Saarbrücken, Germany. lengauer@mpi-sb.mpg.de

Drug Discovery Today
|February 6, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PegaPlus─Interactive Machine Learning by Human Observation for Efficient Clustering and Analysis of Structure-Activity Data.

Journal of chemical information and modeling·2026
Same author

Enabling Automatic Generation of Protein-Ligand Complex Data Sets with Atomistic Detail.

Journal of chemical information and modeling·2026
Same author

Guiding Similarity Search in Chemical Fragment Spaces with Weighted Fingerprints.

Journal of chemical information and modeling·2026
Same author

ActivityFinder: Toward the Fully Automatic Integration of Structural and Binding Affinity Data.

Journal of chemical information and modeling·2026
Same author

Geno2pheno: recombination detection for HIV-1 and HEV subtypes.

NAR molecular medicine·2025
Same author

Efficient and accurate search in petabase-scale sequence repositories.

Nature·2025
Same journal

Targeting the GLP-1 receptor pathways for dual management of obesity and depression.

Drug discovery today·2026
Same journal

Chemical intervention strategies targeting MYC for cancer therapy.

Drug discovery today·2026
Same journal

How many protein pairs can we chemically target?

Drug discovery today·2026
Same journal

From trial-and-error to inverse design: how AI is redefining drug delivery systems.

Drug discovery today·2026
Same journal

Critical evaluation of the key mediators causing life-threatening symptoms during human anaphylaxis.

Drug discovery today·2026
Same journal

A20 as a novel immunoregulatory target for neuroinflammation.

Drug discovery today·2026
See all related articles

This study reviews virtual screening methods for drug discovery, focusing on structural ligand similarity analysis. It complements existing reviews by detailing approaches that consider complete molecule structures for identifying protein binders.

Area of Science:

  • Computational chemistry
  • Medicinal chemistry
  • Drug discovery

Background:

  • Virtual screening (VS) is crucial for identifying small organic compounds that bind tightly to protein targets.
  • Existing reviews primarily cover docking and pharmacophore searching methods.
  • There is a need to focus on VS methods analyzing ligand similarity at a structural level.

Purpose of the Study:

  • To complement existing reviews on virtual screening by focusing on structure-based ligand similarity methods.
  • To discuss virtual screening (VS) in relation to high-throughput screening (HTS).
  • To summarize new developments and offer future perspectives in structural virtual screening.

Main Methods:

  • Analysis of virtual screening methods based on structural similarity of complete ligand molecules.

Related Experiment Videos

  • Comparison of structural VS with pharmacophore searching and docking.
  • Discussion of the in silico procedure of VS and its experimental counterpart, HTS.

    • Main Results:

    • Structural ligand similarity analysis offers a complementary approach to docking and pharmacophore searching.
    • Methods exploiting complete ligand structural properties are highlighted.
    • The relationship between in silico VS and experimental HTS is explored.

    Conclusions:

    • Structural ligand similarity methods provide valuable alternatives for virtual screening in drug discovery.
    • Future research should continue to develop and refine these structure-based VS approaches.
    • Understanding the interplay between VS and HTS is key for efficient drug candidate identification.